Therapeutic Value of Single Nucleotide Polymorphisms on the Efficacy of New Therapies in Patients with Multiple Sclerosis

The introduction of new therapies for the treatment of multiple sclerosis (MS) is a very recent phenomenon and little is known of their mechanism of action. Moreover, the response is subject to interindividual variability and may be affected by genetic factors, such as polymorphisms in the genes imp...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Pers Med
Autori principali: Zarzuelo Romero, María José, Pérez Ramírez, Cristina, Carrasco Campos, María Isabel, Sánchez Martín, Almudena, Calleja Hernández, Miguel Ángel, Ramírez Tortosa, María Carmen, Jiménez Morales, Alberto
Natura: Artigo
Lingua:Inglês
Pubblicazione: MDPI 2021
Soggetti:
Review
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8146426/
https://ncbi.nlm.nih.gov/pubmed/33922540
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jpm11050335
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi